ST Pharm Co.,Ltd. (KOSDAQ: 237690)
South Korea
· Delayed Price · Currency is KRW
84,400
-700 (-0.82%)
Dec 20, 2024, 11:29 AM KST
ST Pharm Co.,Ltd. Company Description
ST Pharm Co.,Ltd., provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.
The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics.
It also offers pre-clinical and bioanalytical R and D solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.
ST Pharm Co.,Ltd.
Country | South Korea |
Founded | 1983 |
Industry | Medicinal Chemicals and Botanical Products |
Employees | 655 |
CEO | Mooje Sung |
Contact Details
Address: Sihwa Industrial Complex 1na 802 Siheung-si, 15086 South Korea | |
Phone | 82 3 1488 1300 |
Website | stpharm.co.kr |
Stock Details
Ticker Symbol | 237690 |
Exchange | KOSDAQ |
Fiscal Year | January - December |
Reporting Currency | KRW |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Mooje Sung | Chief Executive Officer |
YiHwan Kim | Chief Financial Officer |